Regulatory News
Thursday, June 16, 2016
BRIEF-Bellerophon enrolls first patient in phase 3 trial for pulmonary arterial hypertension
* 1 phase 3 clinical trial for pulmonary arterial
hypertension (pah)
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment